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ABSTRACT  
  
Objective and design The aim of this study is to evaluate the expression of the histamine receptors, 
particularly focusing on the H4R in human renal tubules.  
Material The ex-vivo evaluation was carried on specimens from human renal cortex. Primary and 
immortalized tubular epithelial cells (TECs) and the HK-2 cell line were used as in vitro models.  
Treatment Cells were pretreated for 10 min with chlorfeniramine maleate 10 µM (H1R antagonist), 
ranitidine 10 µM (H2R antagonist), GSK189254 1 µM (H3R antagonist) or JNJ7777120 10 µM (H4R 
antagonist), and then exposed to histamine (3 pM - 10 nM) for 30 min.  
Methods The ex-vivo evaluation on specimens from human renal cortex was performed by 
immunohistochemistry. The expression of histamine receptors on primary and immortalized TECs and the 
HK-2 cell line was evaluated at both gene (RT-PCR) and protein (immunocytofluorescence) levels. The 
pharmacological analysis was performed by TR-FRET measurements of second messenger (IP3 and 
cAMP) production induced by histamine with or without the selective antagonists. 
Results Our data revealed the presence of all histamine receptors in human tubules; however, only TECs 
expressed all the receptors. Indeed, histamine elicited a sigmoid dose-response curve for IP3 production, 
shifted to the right by chlorpheniramine maleate, and elicited a double bell-shaped curve for cAMP 
production, partially suppressed by the selective H2R, H3R and H4R antagonists when each added alone, 
and completely ablated when combined together.  
Conclusions Herein, we report the identification of all four histamine receptors in human renal tubules. 
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Introduction 
 
Histamine is a pleiotropic amine ubiquitously distributed, that exerts its effects through four subtypes of G-
protein coupled receptors, namely H1 receptor (H1R), H2 receptor (H2R), H3 receptor (H3R) and H4 receptor 
(H4R), differentially expressed in various tissues and cell types. The presence of histamine in the kidney 
has been detected for decades. It can derive from resident mast cells [1], glomerular cells, which have been 
reported as a major site of intrarenal histamine synthesis and accumulation [2], and from proximal tubular 
epithelial cells, where the expression of the enzyme histidine decarboxylase (HDC) has been demonstrated 
[3]. 
Indirect evidence sustains the hypothesis that histamine could be involved in renal physiology in humans. 
In healthy subjects the administration of loading doses of L-histidine led to an increase of histamine 
concentration in urine, but not in blood [4]. In renal transplant patients the urinary and blood levels of 
histamine are elevated [5]. Moreover, some evidence suggest that histamine may be involved in diabetes-
related kidney disease. Indeed, in the kidney of diabetic rats, histamine was increased compared with 
controls[6, 7]. Independent studies indicate that histamine regulates the renal microcirculation, by 
increasing salt and water excretion[8-10], decreasing the ultrafiltration coefficient by reducing the total 
filtration surface area [10], and increasing renin release [11]. 
The renal effects of histamine have been first ascribed only to H1R and H2R, both identified in the 
glomeruli [12, 13]. Recently, a possible role for H4R has been suggested by our research group [14]. While 
a very low mRNA level of the latest discovered histamine receptor has been reported in the kidney of dog, 
monkey, rat, mouse, guinea pig and pig [15-20], in 2013 we demonstrated the presence of H4R in resident 
renal cells of the loop of Henlé!and its profound upregulation in the kidney of diabetic rats [14]. Notably, 
these data provide the first basis to hypothesize a possible involvement of H4R in the onset/progression of 
diabetes-associated renal disease. However, this study, as well as the majority of the previous research, was 
conducted on rodents and the demonstration of the presence of the histamine receptors in the human kidney 
  
is still lacking. Thus, herein we aimed to extend our previous observation on renal H4R from rats to 
humans. The study herein was focused on the renal tubules and the H4R was evaluated in different cells, by 
using both the immortalized human proximal tubular epithelial cell line Human Kidney 2 (HK-2), and 
human tubular epithelial cells (TECs). Moreover, herein we broadened our investigation to all of the four 
histamine receptors.  
 
Materials and Methods 
Reagents 
All reagents and chemicals used were from Sigma–Aldrich (St. Louis, MO) unless otherwise noted. 
GSK189254 (PubMed CID 24768876) was kindly supplied by Prof. E. Masini, University of Florence, 
Italy. Cell media and cell reagents were from Lonza group Ltd. (Allendale, NJ, USA). Hanks Balanced Salt 
Solution was from GIBCO (Grand Island, NY). RevertAid™!First Strand cDNA Synthesis Kit as well as 
SuperSignal West Pico Chemiluminescent Substrate were from Thermo Fisher Scientific Inc. (Rockford, 
IL, USA), EuroTaq DNA polymerase was from Euro-clone (Milan, Italy). Sequence-specific 
oligonucleotide primers were purchase from Sigma-Genosys (Milan Italy). The antibodies for histamine 
H1R (H300, sc-20633) and H2R (S20, sc-33973) as well as UltraCruz™! Autoradiography Film were 
purchased from Santa Cruz Biotechnology Inc. (Dallas, TX, USA), while anti-rabbit and anti-mouse IgG 
HRP-linked antibodies were from Cell Signaling Technology, Inc. (Danvers, MA, USA) and the swine 
anti-Goat IgG antibody from Cedarlane Labs (Ontario, Canada). BCA protein assay was from Pierce Bio-
technology Inc. (Rockford, IL, USA) and PVDF membrane from Millipore (Bradford, MA, USA). The 
LANCE®! Ultra cAMP Detection Kit and the IP-One HTRF®! assay kit were from PerkinElmer Inc. 
(Waltham, MA, USA) and Cisbio Bioassays (France), respectively.  
Histamine dihydrochloride (PubMed CID 5818), chlorpheniramine maleate (PubMed CID 5281068), 
Ranitidine hydrochloride (PubMed CID 3033332), GSK189254 and JNJ7777120 (PubMed CID 4908365) 
were dissolved in dimethyl sulfoxide, and the final drug concentrations were obtained by dilution of stock 
  
solutions in the experimental buffers. The final concentration of the organic solvent was less than 0.1%, 
which had no effect on cell viability. 
 
Antibodies 
H3R and H4R were detected by using the anti-hH3R (349–358) and the anti-hH4R (374–390) antibodies 
produced and validated for detecting both human and rodent H3R and H4R in the School of Biological and 
Biomedical Sciences, Durham University [21-27]. Briefly, anti-hH3R antibody was generated coupling the 
peptide corresponding to the amino acids RLSRDRKVAK Cys of the human and rat H3R to thyroglobulin 
by m-maleimidobenzoic acid N-hydroxysuccinimide ester coupling method as described previously [6] and 
antibodies were raised in rabbits to the resultant conjugate. Anti-peptide antibody production was 
monitored by enzyme-linked immunosorbent assay with the peptide H3 (349–358) as the antigen. The anti-
hH4R antibody was generated against the last 17 amino acids of the C-terminal tail of the H4R conjugating 
the peptide corresponding to the amino acids CIKKQPLPSQHSRSVSS to thyroglobulin by the cysteine-
coupling method [28]. The resultant conjugate was used to generate polyclonal antibodies in rabbits. The 
selectivity of the anti-hH4R antibody was confirmed by blockade with the C-terminal peptide of the H4R 
and a lack of cross-reactivity with the human H3R, the most closely related G-coupled receptor [21]. The 
antibodies for histamine H1R (H300, sc-20633) and H2R (A20, sc-19773), were purchased from Santa Cruz 
Biotechnology Inc. (Dallas, TX, USA). 
 
Immunohistochemistry  
Conventional immunohistochemical procedures were employed as described previously [14, 29, 30]. 
Briefly, immunoperoxidase staining for H1R, H2R, H3R and H4R was performed on 5 µm sections for 
formalin-fixed tissue from 12 patients who underwent elective nephrectomy as first line therapy for renal 
carcinoma at the Urology Surgery of the A.O.U. Città!della salute e della Scienza of Turin, Italy, after 
approval of the Ethical Committee for the use of human tissue of the Department of Medical Sciences of 
  
the University of Turin, Italy. Incubation with sodium citrate 50 mM pH 8.4 for 30 min at room 
temperature followed by sodium citrate 50 mM pH 8.4 for 30 min at 80°C was performed for antigen 
retrival. Sections were incubated overnight with anti-H1R (1.3 µg/ml), anti-H2R (1.3 µg/ml), anti-H3R (1 
µg/ml) or anti-H4R (2 µg/ml) receptor subunit at 4°C, followed by a three-layer streptavidin–biotin–
peroxidase complex staining method (Vectastain ABC Elite kit and 3',3-diaminobenzadine 
tetrahydrochloride, DAB; Vector Laboratories, Inc.). Tissue was also screened in the absence of primary 
antibody, where in all cases, a major part of the staining was abolished (data not shown). All sections were 
stained or immunostained in a single session to minimize artifactual differences in the staining. 
Photomicrographs of the histological slides were acquired randomly with a digital camera connected to a 
light microscope equipped with a ×20 objective (Olympus BH2). 
 
Cell cultures 
In this study, the following cell types primary (p) and immortalized (i) TECs from human renal cortex and 
HK-2 cell line were used. Primary cultures were obtained from the normal portion of cortex surgically 
removed kidneys (n=5) as described previously [31]. The healthy tissue was derived from kidney samples 
of patients who underwent unilateral nephrectomy due to renal carcinomas as first line treatment. To our 
knowledge, no other relevant pathology was diagnosed in the medical history of each patient enrolled and 
no drugs able to induce histamine release were used in treatment. Briefly, after dissection of the cortex and 
passage through a graded series of meshes, a mixed population of pTECs was plated in DMEM containing 
1 mg/l glucose supplemented with 10% FCS, penicillin/streptomycin (100 IU/ml), and l-glutamine and the 
cultures were maintained at 37 °C in a 95% air/5% CO2 humidified incubator. iTECs were obtained from 
the respective primary cells by infection with a hybrid Adeno5/SV40 virus as previously described [31-34]. 
These cells showed negative staining for von Willebrand factor, minimal staining for desmin, and marked 
staining with antibodies to cytokeratins, actin, and alkaline phosphatise [32]. Primary cultures were used 
within first three passages. HK-2, immortalized human proximal tubular epithelial cells from American 
  
Type Culture Collection (Number CRL-2190), were cultured in DMEM containing 1 mg/l glucose 
supplemented with 10% FCS, penicillin/streptomycin (100 IU/ml), and l-glutamine and the cultures were 
maintained at 37 °C in a 95% air–5% CO2 humidified incubator. 
 
RT-PCR 
Two µg/µl of total RNA extracted from kidney epithelial cells was processed by RevertAid™!First Strand 
cDNA Synthesis Kit according to the manufacturer’s instruction and were subjected to RT-PCR as 
previously described [35]. Briefly, RT-PCR amplifications were performed in 25 µl reaction mixtures 
containing 2µl of cDNA, 2.5 µl of 10X buffer, 1.0 µl of 50 mM MgCl2, 0.20 µl of 25 mM dNTPs mix, 0.05 
U of EuroTaq DNA polymerase, and 2.5 µl of 5 µM sequence-specific oligonucleotide primers reported in 
Table 1. PCR amplicons were resolved in an ethidium bromide-stained agarose gel (2.5 %) by 
electrophoresis. GADPH gene expression was used as an internal control. 
 
Immunocytofluorescence  
Cells were fixed with 4% paraformaldehyde in PBS and permeabilized with 0.1% TritonX-100. 
Immunofluorescence was performed using the indicated antibodies against the histamine receptors, 
followed by incubation with Alexa-Conjugated secondary antibodies (Invitrogen). Nuclei were stained with 
Hoescht (Sigma). All the slides were examined at ×40 magnification using Apotome systems (Zeiss). 
 
Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) 
The TR-FRET assay was used to evaluate cellular cAMP and IP1 production using the LANCE®!Ultra 
cAMP Detection Kit and the IP-One HTRF®! assay kit, respectively, according to the manufacturer's 
instruction. Briefly, for cAMP 10,000 cells/well, pretreated with vehicle alone or with ranitidine 1 µM or 
10 µM (H2R antagonist), GSK189254 0.1 µM or 1 µM (H3R antagonist) or JNJ7777120 1 µM or 10 µM 
(H4R antagonist) for 10 min, were exposed to histamine in the range 3 pM - 10 nM for 30 min in presence 
  
of IBMX 0.5 mM. After 1 h incubation at room temperature with Eu3+-labeled antibody and 
allophycocyanin-labeled antibody, energy transfer was measured by exciting the Eu3+ at 320 nm and 
monitoring the allophycocyanin emission at 665 nm using the multiple plate reader Victor X (PerkinElmer 
Inc.). Data were expressed as TR-FRET signal over the basal one. 
Similarly, for IP1, the downstream stable metabolite of IP3, 50,000 cells/well were pre-treated with vehicle 
alone or chlorpheniramine maleate 1 µM or 10 µM (H1R antagonist) for 10 min and exposed to histamine 
in the range 3 pM - 300 nM for 1 h. After incubation for 1 h at room temperature with IP-One Tb conjugate 
and Lumi4™-Tb cryptate-label antibody, energy transfer was measured by exciting the Lumi4™-Tb 
cryptate at 320 nm and monitoring the emission at both 620 and 665 nm using the multiple plate reader 
Victor X. Results are expressed as the 665nm/620nm ratio over the basal one. 
 
Statistical analysis 
In some cases (Fig. 3 and Fig. 5), data were best-fitted as sigmoid concentration–response curves, and 
analyzed with a four-parameter logistic equation by using the software Origin version 6.0 (Microcal 
Software, Northampton, MA). Results are shown as mean ±!SEM and were analyzed by Student’s t-test or 
one-way ANOVA with Dunnett’s multiple comparison to determine significant differences between mean 
values: P-values < 0.05 were considered significant. Data analysis was performed testing for normality 
using the Klmogorov-Smirnov test by Prism 4 software from Graphpad (CA, USA). 
 
Results 
Histamine receptor identification in the human renal tubules 
To evaluate the expression of the four histamine receptors, 12 human renal cortex specimens were 
subjected to immunohistochemical analysis. As showed in Fig. 1, immunolabeling for each of the 
antibodies tested was detected in the tubules, thus suggesting that all four receptor subtypes are present. In 
particular, specific H1R, H2R and H4R immunoreactivities were found at the tubular level, with a robust 
  
positivity for H4R at the basal membrane of some tubular epithelial cells. Most intriguingly, 
immunolabelling sections with the anti-H3R antibody yielded staining only on some tubule epithelium, with 
a stronger signal at the apical membrane. No staining was detected with specimens probed in the absence of 
primary antibodies (not shown). 
 
Histamine receptor expression in human renal cells 
The expression of the four histamine receptors was evaluated at both gene (Fig. 2A) and protein (Fig. 2B) 
levels in different human tubular epithelial cells (HK-2, iTECs and pTECs). As shown in Fig. 2A, single 
transcripts corresponding to the size predicted for H1R (403 bp), H2R (497 bp), H3R (221 bp) and H4R 
(353 bp) were obtained in both pTECs and iTECs. Consistently, both the cell cultures showed positive 
staining for all four receptors when the protein expression was evaluated by immunofluorescence (Fig. 2B). 
These results indicate that all the histamine receptor subtypes are expressed in these cells. Given the 
similarity between primary and immortalized cells, we used the immortalized cells for the next set of 
experiments. In comparison to all TECs tested, only the single transcripts corresponding to the size 
predicted for H1R and H4R were observed in HK-2, while the transcript corresponding to the size predicted 
for H2R was undetectable. H3R protein was confined to some cells from tubules, but no transcript for H3R 
was detected on the HK-2 cell line (Fig. 2A). 
These results were confirmed when histamine receptors were analyzed by immunofluorescence. Indeed, as 
shown in Fig. 2B, H1R showed a diffuse staining in all the cells tested, with a predominant localization in 
the membrane of some HK-2 cells and in the perinuclear zone in iTECs. In comparison, when H4R was 
considered, diffuse staining was observed with a prevalent signal at the cytoplasmic level; however, a 
membrane localization of H4R signal was also found in some iTECs. A similar result was obtained for H2R: 
detected in the cytoplasm; it was also clearly visible on the membrane in iTECs. Finally, H3R was only 
expressed by iTECs. Similarly to iTECs, pTECs expressed all the four histamine receptor subtypes. 
 
  
Second messenger production evoked by histamine in human renal cells 
In order to confirm the functional expression of the histamine receptors suggested by RT-PCR and antibody 
labelling, we tested the activation of the histamine receptors evaluating the production of second 
messengers in iTECs, and HK-2 cell line challenged with histamine utilizing a TR-FRET assay. 
To evaluate the effect of histamine on the activation of the H1R, a Gq protein-coupled receptor, the levels of 
IP1, the downstream more stable metabolite of IP3, were measured. Cells exposed for 1 h to histamine 3 pM 
- 300 nM showed a concentration-dependent decrease in TR-FRET signal (Fig. 3), which indicates an 
increase of IP1. Notably, a concentration-dependent relationship was reported for both the cell types. 
Different EC50s for histamine were observed: 0.56!±!0.04 nM for HK-2 (Fig. 3A) and 8.84 ±!0.89 nM for 
iTECs (Fig. 3B). The pre-treatment for 10 min with the selective H1R antagonist chlorpheniramine maleate 
at either 1 µM or 10 µM shifted in a concentration-dependent manner the curves evoked by histamine, thus 
confirming the functional expression of H1R in the renal cells. However, differences between the two cell 
lines were still observed, with chlorpheniramine maleate exerting a surmountable antagonism in HK-2 cells 
(Fig. 3A) and an apparent non-competitive antagonism in iTECs (Fig. 3B). 
To evaluate the effect of histamine on the activation of the Gs protein, preferentially coupled with H2R, and 
Gi protein, coupled with both H3R and H4R, protein, the levels of cAMP were measured. As shown in Fig. 
4, iTECs exposed for 30 min to histamine 3 pM - 10 nM produced a double bell-shaped dose-response 
curve: the first in the 3 pM –!0.1 nM range, with the maximum increase in TR-FRET signal at 0.02 nM, the 
second in the 0.1 –!10 nM range, with the maximum increase achieved at 0.4 nM (Fig. 4A). When singly-
administrated, ranitidine 1!µM or 10!µM modified both of the two peaks of cAMP production at 0.1 nM 
and 10 nM, respectively (Fig. 4B), GSK189254 0.1 µM or 1 µM suppressed the second bell-shaped curve 
(Fig. 4C), while JNJ7777120 (1 µM or 10 µM) ablated the first high-affinity histamine response (Fig. 4D). 
Notably, the co-administration of all three antagonists completely abolished the effect evoked by histamine 
(Fig. 4E). Thus, the data herein obtained are consistent with the presence of H2R, H3R and H4R. In 
comparison to iTECs, the HK-2 cell line (Fig. 5) displayed a single sigmoid increase in TR-FRET signal 
  
(EC50 1.04 ±!0.15 nM), suggesting that only a Gi protein coupled receptor is expressed. The antagonism 
produced by JNJ7777120 10 µM indicates that the contributing receptor to this latter effect is the H4R. 
 
Discussion 
This study provides the first comparative evaluation of the four histamine receptor expression in the human 
renal tubules. Whether functional histamine receptors are expressed by human renal cells has been scantly 
investigated, with studies identifying H1R and H2R based on the use of pharmacological tools [32, 33]. 
Herein, by using a combined molecular, anatomical and pharmacological strategies, we provide convergent 
lines of evidence strongly supporting the conclusions that all histamine receptors are present in the kidney. 
In particular, our study was focused on tubules, where we demonstrate that all of the histamine receptors 
are expressed on epithelial cells. 
Our in vitro observations were performed on two epithelial tubular cell lines iTECs and HK-2. iTECs were 
isolated from human renal cortex and represent a mixed population of tubular epithelial cells, while HK-2 
is a commercially available pure proximal tubular epithelial cell line, selected for study based on the 
assumption that the most abundant epithelial tubular cells within the cortex are proximally located. 
Moreover, to avoid bias due to the cell immortalization process, we also compared primary cells pTECs to 
the corresponding immortalized human cells. 
H1R, H2R and H4R were found in all the cell types tested, thus demonstrating an even distribution along the 
tubules; while H3R was confined to a minor subpopulation of renal cells as expressed only by TECs. These 
data extend the previous findings on the localization of H1R and H2R in mammalian glomeruli [2, 13, 36] to 
other nephron components, such as tubular epithelial cells. Moreover, we extended our recent observation 
on H4R expression in the kidney of rats [14], now demonstrating its expression on human proximal tubular 
cells. Although we previously reported that in the kidney of rats the H4R is expressed by resident renal cells 
of the loop of Henlé, and not by proximal tubular cells as observed in humans, these two apparently 
contrasting observations are in keeping with the intra-species differences of H4R expression already widely 
  
reported [16]. Moreover, the present study was performed only on renal cortex derived specimens and cells, 
thus a wider distribution also in the medulla and on the epithelial cells of the human loop of Henlé!could 
not be ruled out. 
An original and unexpected result of our study is the H3R identification on renal tubular epithelial cells. It 
has been largely demonstrated that H3R is mostly expressed in the central and, to a lesser extent, in the 
peripheral nervous system. Only a small number of experimental observations have showed its presence on 
non-neuronal cell types such as rodent fundic mucosa endocrine cells [26], cholangiocytes [37], pancreatic 
β-cells [38], and in the human bronchial epithelial cell line BEAS-2B [39]. Therefore, our data add a new 
non-neuronal localization of the H3R, contributing to the hypothesis that the H3R could also mediate non-
neuronal histamine effects. It is not sufficient to claim the presence of histamine receptors in the renal 
tubules based purely on PCR and immunological techniques, thus a pharmacological approach was adopted 
herein to provide stronger evidence for the presence of functional histamine receptors. 
The canonical H1R-mediated response (second messenger IP3, evaluated by IP1) was measured in both HK-
2 and iTECs, consistent with the observed H1R mRNA and protein expression. The involvement of 
histamine-mediated cAMP response was also demonstrated in both of the cell types tested. In HK-2, 
although both H2R and H4R were identified at both the gene and protein level, histamine evoked only a 
reduction in cAMP, consistent with a Gi-protein coupled receptor such as H4R. Indeed, JNJ7777120 
completely ablated the histamine-evoked effect in this cell line. This finding, in keeping with the apparent 
largely cytoplasmatic localization of H2R, suggests that in HK-2, this receptor is non-functional. Perhaps, 
the presence of nM histamine in the media (results not shown) has down-regulated this receptor. 
The complex non-sigmoid shape of the concentration-response curve observed in iTECs for cAMP is likely 
a composite of the response evoked by histamine through H2R, H3R and H4R. Indeed, only the co-
administration of ranitidine, GSK189254 and JNJ7777120 completely blunted the effect evoked by 
histamine in iTECs. The EC50s observed for H1R-mediated response ranged from 0.56!±!0.04 nM for HK-2 
to 8.84 ±!0.89 nM for iTECs. For H4R in HK-2 cell line, the EC50 was 0.97 ±!0.02 nM; in iTECs the effect 
  
of histamine through H4R was displayed at picomolar concentrations. These differences in the EC50s 
between the two cell lines could be ascribed to the different intracellular localization of the histamine 
receptors: H1R and H4R displayed a predominant membrane localization in the HK-2 and iTECs, 
respectively. Notably, the values of EC50 herein determined are lower than the Kd values reported for each 
receptor challenged by the natural ligand. It is known that H1R and H2R have an affinity in the micromolar 
range, whereas H3R and H4R are high-affinity receptors with Kd values of 5–10 nM [40]. The discrepancy 
between both the measured EC50s and the reported Kd values, and the discrepancies among the tested cell 
types could be explained by differences in receptor reserves [41], species variance and/or the presence of 
isoforms, already reported for H3R and H4R [27]. It has been reported that the H4R splice variants are able 
to retain H4R 390 (the full length variant) intracellularly [27]. The possible presence of different dominant 
negative H4R variants is in keeping with the cytoplasmatic staining observed when cells were 
immunolabelled with the anti-full length H4R isoform antibody. Furthermore, the presence of nM histamine 
(results not shown) in the media may also increase the apparent potencies of histamine in these functional 
studies. The apparent non-competitive behavior displayed by chlorpheniramine maleate in iTECs, 
compared to the surmountable antagonism showed in HK-2, is in keeping with previous observations of a 
pronounced non-competitive antagonism of first generation H1R antagonists in some cellular system such 
as HL-60 and HeLa cells, and could be explained by non-equilibrium conditions, as already reported [42]. 
In conclusion, our results provide the first dual anatomical and functional identification of the histamine 
receptor family in human kidney tubules. This new knowledge will foster a better understanding of the 
roles of histamine in renal pathophysiological conditions and may contribute to new therapeutic 
approaches.  
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Fig. 1. Histamine receptor expression in the human renal tubules  
 
Representative micrographs of 12 different human renal cortex section from apparently healthy tissue of 
patients underwent to elective nephrectomy, immunolabelled with specific anti-H1 anti-H2, anti-H3, or anti-
H4 receptor antibodies, respectively. 
 
Fig. 2. Histamine receptor expression in renal epithelial cell lines from human cortex 
 
A: Agarose gels representative of three different RT-PCR assays for cDNA from tubular derived cells 1= 
HK-2 cell line, 2= pTECs and 3= iTECs. Single transcript corresponding to the size predicted for H1R (403 
bp), H2R (497 bp), H3R (221 bp), and H4R (353 bp) were detected. The housekeeping gene GAPDH was 
used as control. B: Representative merged immunofluorescence images (original magnification 400X) 
labelled with specific anti-H1 anti-H2, anti-H3, or anti-H4 receptor antibodies (green), respectively, and 
Hoescht (blue). The micrographs are representative of at least three independent experiments with similar 
results.  
 
Fig. 3. IP1 production in different renal epithelial cell lines from human cortex 
The levels of IP1, downstream metabolite of IP3, were measured, according to the manufacturer’s 
instruction, by IP-One HTRF®!assay kit (Cisbio) in HK-2 (A) and iTECs (B): 50,000 cells/well pretreated 
for 10 min with vehicle alone (black square, solid line) or the selective H1R antagonist, chlorpheniramine 
maleate 1 µM (black circle, dash-dot line) or 10 µM (white circle, dash line), were exposed to histamine (3 
pM –!300 nM) for 1 h. Results, calculated from the 665nm/620nm ratio, are expressed as increase over the 
  
basal and are the mean ±! SEM of 3 independent experiments run in duplicate. Statistical analysis was 
performed by one-way ANOVA and Dunnett test. 
 
Fig. 4. cAMP production in tubular epithelial cells  
cAMP was measured, according to the manufacturer’s instruction, by LANCE Ultra cAMP assay 
(PerkinElmer) in iTECs: 10,000 cells/well, pretreated for 10 min with vehicle alone (A) or the selective 
H2R antagonist, ranitidine 1 µM (black turbot) or 10 µM (white turbot) (B), the selective H3R antagonist, 
GSK189254 0,1 µM (black triangle) or 1 µM (white triangle) (C), or the selective H4R antagonist, 
JNJ7777120 1 µM (black star) or 10 µM (white star) (D) alone, or co-administrated (E) were exposed to 
histamine (3 pM –!10 nM) for 30 min. Results, expressed as TR-FRET signal at 665 nm over the basal, are 
the mean ±!SEM of 3 independent experiments run in duplicate. Statistical analysis was performed by one-
way ANOVA and Dunnett test. *P <0.05; **P <0.01; ***P <0.001 vs 0 and #P <0.05; ##P <0.01 vs higher 
dose. 
 
Fig. 5. cAMP production in HK-2 cell line  
cAMP was measured, according to the manufacturer’s instruction, by LANCE Ultra cAMP assay 
(PerkinElmer) in HK-2 cells: 10,000 cells/well, pretreated for 10 min with vehicle alone (black square, 
solid line) or the selective H4R antagonist, JNJ7777120 1 µM (black star) or 10 µM (white star), were 
exposed to histamine (3 pM –!10 nM) for 30 min. Results, expressed as TR-FRET signal at 665 nm over 
the basal, are the mean ±! SEM of 3 independent experiments run in duplicate. Statistical analysis was 
performed by one-way ANOVA and Dunnett test. **P <0.01; ***P <0.001 vs 0 and #P <0.05; ##P <0.01; 
###P <0.001 vs higher dose. 
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